Although newly diagnosed glioblastoma had the highest plasmafold changes for TNC+/CD63+ EVs than HD, weakor insignificant differences were found for this subpopulation inrecurrent patients compared to HD and post-OP subjects. This evidence concerns the gene CD63 and glioblastoma.